124 related articles for article (PubMed ID: 37315399)
1. Prognostic evaluation of cancer associated fibrosis and tumor budding in colorectal cancer.
Khan AA; Malik S; Jacob S; Aden D; Ahuja S; Zaheer S; Ranga S
Pathol Res Pract; 2023 Aug; 248():154587. PubMed ID: 37315399
[TBL] [Abstract][Full Text] [Related]
2. The Prognostic Impact of Tumor Border Configuration, Tumor Budding and Tumor Stroma Ratio in Colorectal Carcinoma.
Aboelnasr LS; El-Rebey HS; Mohamed A; Abdou AG
Turk Patoloji Derg; 2023; 39(1):83-93. PubMed ID: 35642343
[TBL] [Abstract][Full Text] [Related]
3. Tumor Budding and PDC Grade Are Stage Independent Predictors of Clinical Outcome in Mismatch Repair Deficient Colorectal Cancer.
Ryan É; Khaw YL; Creavin B; Geraghty R; Ryan EJ; Gibbons D; Hanly A; Martin ST; O'Connell PR; Winter DC; Sheahan K
Am J Surg Pathol; 2018 Jan; 42(1):60-68. PubMed ID: 29112018
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of lymphovascular invasion in stage II colorectal cancer patients with an inadequate examination of lymph nodes.
Gao Z; Cao H; Xu X; Wang Q; Wu Y; Lu Q
World J Surg Oncol; 2021 Apr; 19(1):125. PubMed ID: 33866973
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of desmoplastic stromal reaction, tumor budding and tumor-stroma ratio in stage II colorectal cancer.
Fan S; Cui X; Zheng L; Ma W; Zheng S; Wang J; Qi L; Ye Z
J Gastrointest Oncol; 2022 Dec; 13(6):2903-2921. PubMed ID: 36636094
[TBL] [Abstract][Full Text] [Related]
6. Concurrent Comparison of the Prognostic Values of Tumor Budding, Tumor Stroma Ratio, Tumor Infiltrating Pattern and Lymphocyte-to-Monocyte Ratio in Colorectal Cancer Patients.
Zhang Y; Liu Y; Qiu X; Yan B
Technol Cancer Res Treat; 2021; 20():15330338211045826. PubMed ID: 34658263
[No Abstract] [Full Text] [Related]
7. [Retrospective investigation of patients receiving additional surgery after endoscopic non-curative resection for early colorectal cancer].
Sun YM; Zhang DS; Feng YF; Wang Y; Xu ZW
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 May; 23(5):486-491. PubMed ID: 32842429
[No Abstract] [Full Text] [Related]
8. A novel histologic grading scheme based on poorly differentiated clusters is applicable to treated rectal cancer and is associated with established histopathological prognosticators.
Yang M; Rehman AU; Zuo C; Sheehan CE; Lee EC; Lin J; Zhao Z; Choi E; Lee H
Cancer Med; 2016 Jul; 5(7):1510-8. PubMed ID: 27165693
[TBL] [Abstract][Full Text] [Related]
9. Histologic grading based on counting poorly differentiated clusters in preoperative biopsy predicts nodal involvement and pTNM stage in colorectal cancer patients.
Barresi V; Bonetti LR; Ieni A; Branca G; Baron L; Tuccari G
Hum Pathol; 2014 Feb; 45(2):268-75. PubMed ID: 24289972
[TBL] [Abstract][Full Text] [Related]
10. Tumor budding as a prognostic indicator in colorectal carcinoma: a retrospective study of primary colorectal carcinoma cases in a tertiary care center.
Shah AH; Gami AJ; Desai NH; Gandhi JS; Trivedi PP
Indian J Surg Oncol; 2022 Sep; 13(3):459-467. PubMed ID: 36187533
[TBL] [Abstract][Full Text] [Related]
11. The prognostic value of tumour stroma ratio and tumour budding in stage II colon cancer. A nationwide population-based study.
Eriksen AC; Sørensen FB; Lindebjerg J; Hager H; dePont Christensen R; Kjær-Frifeldt S; Hansen TF
Int J Colorectal Dis; 2018 Aug; 33(8):1115-1124. PubMed ID: 29785462
[TBL] [Abstract][Full Text] [Related]
12. The role of tumor budding in colorectal adenocarcinoma: Possible involvement of the intestinal cancer stem cell marker Lgr5.
Sadek SA; A Rehim DM; Fatima S
Indian J Pathol Microbiol; 2020; 63(1):32-37. PubMed ID: 32031119
[TBL] [Abstract][Full Text] [Related]
13. High-grade intratumoral tumor budding is a predictor for lymphovascular invasion and adverse outcome in stage II colorectal cancer.
Marx AH; Mickler C; Sauter G; Simon R; Terracciano LM; Izbicki JR; Clauditz TS
Int J Colorectal Dis; 2020 Feb; 35(2):259-268. PubMed ID: 31838579
[TBL] [Abstract][Full Text] [Related]
14. A Prediction Model for Tumor Recurrence in Stage II-III Colorectal Cancer Patients: From a Machine Learning Model to Genomic Profiling.
Chen PC; Yeh YM; Lin BW; Chan RH; Su PF; Liu YC; Lee CT; Chen SH; Lin PC
Biomedicines; 2022 Feb; 10(2):. PubMed ID: 35203549
[TBL] [Abstract][Full Text] [Related]
15. A novel histologic grading system based on lymphovascular invasion, perineural invasion, and tumor budding in colorectal cancer.
Huh JW; Lee WY; Shin JK; Park YA; Cho YB; Kim HC; Yun SH
J Cancer Res Clin Oncol; 2019 Feb; 145(2):471-477. PubMed ID: 30603899
[TBL] [Abstract][Full Text] [Related]
16. Tumour-stroma ratio outperforms tumour budding as biomarker in colon cancer: a cohort study.
Smit MA; van Pelt GW; Terpstra V; Putter H; Tollenaar RAEM; Mesker WE; van Krieken JHJM
Int J Colorectal Dis; 2021 Dec; 36(12):2729-2737. PubMed ID: 34533595
[TBL] [Abstract][Full Text] [Related]
17. The relationship of tumor budding with GOLPH3 expression and histopathological prognostic parameters in colorectal adenocarcinoma.
Komut N; Bektas S; Yildirim E
Ann Diagn Pathol; 2022 Jun; 58():151933. PubMed ID: 35364414
[TBL] [Abstract][Full Text] [Related]
18. Intra-tumoral budding in preoperative biopsy specimens predicts lymph node and distant metastasis in patients with colorectal cancer.
Giger OT; Comtesse SC; Lugli A; Zlobec I; Kurrer MO
Mod Pathol; 2012 Jul; 25(7):1048-53. PubMed ID: 22481282
[TBL] [Abstract][Full Text] [Related]
19. The presence of poorly differentiated clusters predicts survival in stage II colorectal cancer.
Ammendola S; Turri G; Marconi I; Burato G; Pecori S; Tomezzoli A; Conti C; Pedrazzani C; Barresi V
Virchows Arch; 2021 Feb; 478(2):241-248. PubMed ID: 32577812
[TBL] [Abstract][Full Text] [Related]
20. Histopathologic and Prognostic Significance of Tumor Budding in Colorectal Adenocarcinoma: A Retrospective Cohort Study Conducted in Shiraz, Iran.
Anbardar MH; Rahimizadeh N
Iran J Pathol; 2024; 19(1):59-66. PubMed ID: 38864085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
